Image

Early Warning and Classification Model for Acute Non-traumatic Chest Pain

Early Warning and Classification Model for Acute Non-traumatic Chest Pain

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Acute non-traumatic chest pain is one of the common causes of presentation in emergency patients, but the causes of acute non-traumatic chest pain are complex, the severity of the condition varies greatly, and the specificity of symptoms is not high. Machine learning and intelligent auxiliary models can greatly shorten the time of clinical decision-making, and improve the accuracy of etiological diagnosis in patients with chest pain, reduce the rate of misdiagnosis and missed diagnosis, and provide a clear direction for further treatment.

Description

Prospective observational studies used outpatient and follow-up information to construct an auxiliary early warning model of acute non-traumatic chest pain based on federated learning, and optimized the accuracy of early warning models through retrospective and prospective studies of large cohort data, and established an efficient and stable early warning and classification model for acute non-traumatic chest pain.

Eligibility

Inclusion Criteria:

  1. older than 18 years old;
  2. provided written informed consent;
  3. Outpatient visits in the pilot hospitals from June 2022 to December 2022

Exclusion Criteria:

  1. did not provide written informed consent and were unwilling to be followed up;
  2. traumatic chest pain;
  3. systemic pain caused by malignant tumors or rheumatic diseases involving the chest;
  4. transferred patients;
  5. sudden death or death during hospital treatment;
  6. women who are known to be pregnant or lactating;
  7. have participated in other clinical trials within 3 months before enrolling in this trial or are currently participating in other clinical trials The lender;
  8. According to the investigator's judgment, the patient was unable to complete the study or comply with the requirements of the study;
  9. Patients were lost to follow-up.

Study details
    Chest Pain

NCT06196307

Xiao-nan He

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.